In the context that SARS-CoV-2 causes myocarditis and cardiac injury (36), it is reasonable to believe that the increased ACE2+ in CMs in the failing heart could make these CMs vulnerable to SARS-CoV-2 infection in COVID-19 patients. The gene discussed is ACE2; the disease is myocarditis.